The purpose of this funding opportunity announcement (FOA) is to support and facilitate multidisciplinary approaches towards the development of new and/or improved contraceptive methods for both men and women through the formation of a Contraceptive Development Research Center. This FOA also allows the inclusion of translational studies to facilitate the pre-clinical to clinical transition and increase the likelihood of clinical success. The Center will serve as a national resource for development of early stage investigators electing to pursue careers in contraceptive research.
Deadlines:
RFA-HD-23-029 Expiration Date December 02, 2022
Each Center should propose a budget that reflects the actual needs of the proposed projects and costs; the budget must not exceed $1.3 million per year in direct costs, excluding third party F&A.
The scope of the proposed project should determine the project period. The maximum period of performance is 3 years.
